Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Osteoporosis - Pipeline Assessment and Market Forecasts to' returned 52 results - Page 1 of 3   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Chinese Markets for Osteoporosis Drugs   AMID Co, April 2009, Pages: 166 Regulations Banking System and Regulations Foreign Exchange Taxes, Tariff and Custom Duties III. OSTEOPOROSIS DRUGS INDUSTRY ASSESSMENTS Osteoporosis Drugs Industry Structure Drug Reconstitution at the Point-of-Care: Therapeutic Markets, Technologies, Strategies, and Prospects   Greystone Associates, Jan 2012 - Analyzes therapeutic demand drivers and evaluates the market impact and potential of commercial drug reconstitution systems - Provides analysis of injectable lyophilized drugs and assess key market segments Microneedle Drug Delivery: Technology, Devices, Players, Markets & Prospects   Greystone Associates, May 2011 - Nanobiosciences - Nanomed - NanoPass - Sanofi-Aventis - Theraject - Valeritas - Zosano Near-Terms Markets - Sector Assessments and Forecasts - Antivirals - Dermatology/Cosmetic Surgery - Diabetes - Genetic/DNA Prescription Drug Patches to 2015: Products, Indications, Markets and Opportunities   Greystone Associates, Aug 2011 and patch development issues - Provides assessments of prescription skin patch products in two dozen key market segments - Provides market data and forecasts to 2015 - Profiles patch manufacturers Stakeholder Insight: Osteoporosis - Generic Alendronate Further Establishes Oral Bisphosphonates as Gold Standard   Datamonitor, Oct 2008, Pages: 199 Osteoporosis in children 25 Niche populations with osteoporosis 25 Epidemiology 27 Methodological difficulties in assessing prevalence 27 Differences in the definition of osteopenia, osteoporosis, severe Pen Injectors: Devices, Drugs, Combination Products   Greystone Associates, Jan 2012 Injectors - Therapeutic Sector Assessment Anemia Inflammatory Autoimmune Diseases Diabetes Emergency Medicine Hepatitis Hormone Replacement Multiple Sclerosis Osteoporosis Reproductive Health Other Needle Array Drug Delivery Systems: Devices, Therapeutic Markets, Strategies and Prospects   Greystone Associates, Feb 2012 Needle Arrays Unbranded (PKA SoftTouch) Customizable Needle Arrays Unbranded (Micropoint Technologies) Near-Terms Markets for Needle Arrays - Assessments & Forecasts Dermatology/Cosmetic Surgery Diabetes Inhaled Drug Delivery: Devices, Indications, Therapeutics, Markets and Forecasts   Greystone Associates, Jan 2012 assessments of targeted disease segments, forecast growth and market potential, and therapeutic options · Forecasts the impact of new and emerging inhaled drug therapeutics on healthcare markets Pulmonary Inhalers & Systemic Drug Delivery: Devices, Drugs, Therapeutics, Market Factors & Forecasts   Greystone Associates, May 2010 Pulmonary Inhalers & Systemic Drug Delivery: Devices, Drugs, Therapeutics, Market Factors & Forecasts Advances in drug formulation and inhalation device design are creating new opportunities Injectable Drug Delivery: Drugs, Devices, Targets, Therapeutics and Forecasts   Greystone Associates, Jan 2012 Trial Factors Managed Care and Healthcare Economics Injectable Drug Therapeutics – Segment Assessments and Forecasts Anemia Anticoagulants Growth Hormone Deficiency Hepatitis Inflammatory Autoimmune Next Generation Transdermal Drug Patches: Evolving Technology, Emerging Opportunities   Greystone Associates, Aug 2011 , technologies and patch development issues - Provides assessments of prescription skin patch products in two dozen key market segments - Provides market data and forecasts to 2015 - Profiles patch Chinese Markets for Incretion Drugs   AMID Co, Feb 2009, Pages: 223 . Historical data (1998, 2003 and 2008) and long-term forecasts through to 2013 and 2018 are presented. Major producers in China are profiled. I. INTRODUCTION Report Scope and Methodology Executive Dry Powder Inhalation: Technology, Devices, Markets and Opportunities   Greystone Associates, Jan 2012 - Analyzes and evaluates Dry Powder Inhalers and competing inhaled drug delivery technologies and assesses the market potential for existing and probable future products - Examines Dry Powder Inhaler design Injectable Antibodies. Products, Markets, Players and Forecasts   Greystone Associates, May 2012 Markets Asthma Infectious Disease Oncology Autoimmunity Osteoporosis Macular Degeneration Injectable Antibody Drug Product Assessments and Forecasts Adalimumab (Humira) Alefacept (Amevive) Alemtuzumab Drug Cartridge-based Syringes and Injectors: Devices, Therapeutics, Players, Markets and Prospects   Greystone Associates, April 2011 Analgesics - Opioid Antagonists - Reproductive Hormones - Triptans Cartridge-based Injectables - Market Sector Assessments and Forecasts - Cardiovascular - Immunology - Metabolic -- Diabetes -- Hormone Pen Injectors: Commercial Devices, Combination Products and Market Impact   Greystone Associates, Nov 2010 - Reproductive Hormones - Serotonin Antagonists - Sympathomimetics Pen Injectors - Therapeutic Sector Assessment - Anemia -- Injectable Drugs and Indications -- Commercial Pen Product Analysis -- Forecasts Point-of-Use Drug Reconstitution Systems   Greystone Associates, Jan 2010 and assess key market segments, market dynamics and market demographics - Analyzes therapeutic demand drivers and evaluates the market impact and potential of commercial reconstitution systems - Analyzes Transdermal Skin Patches: Markets and Opportunities 2009   Greystone Associates, March 2009, Pages: 180 chain (ecosystem) companies - Provides detailed assessments of more than thirty patch products in more than a dozen product categories - Charts product sales data, market share, and forecasts to 2012 Opportunities in Nutritional Management: Food and Drinks to Aid Disease Recovery   Business Insights, Sep 2009, Pages: 111 by food companies and clinical nutrition players alike. - Identifies, sizes and forecasts the patient populations for key diseases in which nutritional management can play a key role in aiding recovery Point-of-Delivery Drug Reconstitution Systems   Greystone Associates, Jan 2011 and potential of commercial drug reconstitution systems -Provides analysis of injectable lyophilized drugs and assess key market segments, market dynamics and market demographics - Forecasts Injectable drug Results:  First -   Prev -   1 -   2 -   3 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network